Paxlovid, the “Tamiflu” of COVID-19, the oral medication shown to reduce hospitalizations, also is known for its “rebound” – a recurrence of COVID-19 a few days after completing the entire course of treatment. The New England Journal of Medicine reports on why – it’s the viral load.
